Nutritional Supplementation for Lung Transplant Complications
What You Need to Know Before You Apply
What is the purpose of this trial?
This non-randomized pilot study aims to investigate whether a protein rich nutritional shake (Ensure Enlive) given to patients pre-transplant will decrease skeletal muscle loss (measured by quadriceps ultrasound) and improve nutritional state (measured by Nutritional Risk Index). A nutritional supplement would be a cost-effective solution to treat malnutrition, a known risk factor implicated in poor outcomes for lung transplant recipients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the nutritional supplementation used in lung transplant patients generally safe?
How is the treatment Ensure Enlive unique for lung transplant complications?
Ensure Enlive is unique because it is a nutritional supplement specifically designed to support patients' nutritional needs, which is crucial for lung transplant recipients who often face gastrointestinal complications and require careful nutrition management to improve recovery and manage comorbid conditions.12367
What data supports the effectiveness of the treatment Ensure Enlive for lung transplant complications?
The research highlights the importance of nutrition therapy in managing lung transplant patients, especially those with malnutrition, which is common in conditions like cystic fibrosis. While Ensure Enlive is not specifically mentioned, maintaining adequate nutrition is crucial for recovery and managing complications after lung transplantation.12589
Who Is on the Research Team?
Errol Bush, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are on the waiting list for a single or double lung transplant and have agreed to participate. It's not suitable for individuals with Galactosemia, milk protein allergy, or soy protein allergy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive nutritional shakes (Ensure Enlive) twice per day orally while awaiting lung transplant
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ensure Enlive
Ensure Enlive is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Abbott Nutrition
Industry Sponsor
Robert B. Ford
Abbott Nutrition
Chief Executive Officer since 2020
Bachelor's degree from Boston College, MBA from UC Berkeley, Haas School of Business
Melissa Brotz
Abbott Nutrition
Chief Marketing Officer
Bachelor's degree in Journalism from Northwestern University